M A McKinlay

1.4k total citations
24 papers, 1.1k citations indexed

About

M A McKinlay is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Molecular Biology. According to data from OpenAlex, M A McKinlay has authored 24 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 15 papers in Epidemiology and 7 papers in Molecular Biology. Recurrent topics in M A McKinlay's work include Viral Infections and Immunology Research (15 papers), Respiratory viral infections research (11 papers) and Viral gastroenteritis research and epidemiology (5 papers). M A McKinlay is often cited by papers focused on Viral Infections and Immunology Research (15 papers), Respiratory viral infections research (11 papers) and Viral gastroenteritis research and epidemiology (5 papers). M A McKinlay collaborates with scholars based in United States, Austria and Germany. M A McKinlay's co-authors include Michaël Otto, G. D. DIANA, Margaret Fox, Frank J. Dutko, Michael G. Rossmann, D.C. Pevear, Mark Steven Miller, Peter J. Felock, Adi M. Treasurywala and Thomas J. Smith and has published in prestigious journals such as Journal of Virology, Journal of Medicinal Chemistry and The Journal of Infectious Diseases.

In The Last Decade

M A McKinlay

24 papers receiving 1.0k citations

Peers

M A McKinlay

CCM

EPIDE

ACS

Bart Rombaut Belgium

Jacquelyn Wright-Minogue United States

D.C. Pevear United States

D W Lineberger United States

Rachel Trowbridge Australia

Tatsunori Nakano Japan

Kuo-Ming Lee Taiwan

Angela Skelton United States

Louis M. Schwartzman United States

Manfred Weitz Switzerland

Bart Rombaut Belgium

M A McKinlay

297 ×0.4

CCM

99 ×0.2

EPIDE

231 ×0.7

203 ×0.7

44 ×0.3

ACS

Citations per year, relative to M A McKinlay M A McKinlay (= 1×) peers Bart Rombaut

Countries citing papers authored by M A McKinlay

Since Specialization

Citations

This map shows the geographic impact of M A McKinlay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M A McKinlay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M A McKinlay more than expected).

Fields of papers citing papers by M A McKinlay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M A McKinlay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M A McKinlay. The network helps show where M A McKinlay may publish in the future.

Co-authorship network of co-authors of M A McKinlay

This figure shows the co-authorship network connecting the top 25 collaborators of M A McKinlay. A scholar is included among the top collaborators of M A McKinlay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M A McKinlay. M A McKinlay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xeuatvongsa, Anonh, Joshua A. Mott, M A McKinlay, et al.. (2019). Progress toward sustainable influenza vaccination in the Lao Peoples’ Democratic Republic, 2012–2018. Vaccine. 37(23). 3002–3005. 4 indexed citations

McKinlay, M A, Marc S. Collett, Mark A. Pallansch, et al.. (2014). Progress in the Development of Poliovirus Antiviral Agents and Their Essential Role in Reducing Risks That Threaten Eradication. The Journal of Infectious Diseases. 210(suppl 1). S447–S453. 43 indexed citations

McKinlay, M A. (2001). Recent advances in the treatment of rhinovirus infections. Current Opinion in Pharmacology. 1(5). 477–481. 26 indexed citations

DIANA, G. D., et al.. (1999). Pleconaril. A broad spectrum antipicornaviral agent.. PubMed. 458. 69–76. 25 indexed citations

Zhao, Rui, Marcia J. Kremer, Richard Kühn, et al.. (1996). Crystal structure of human rhinovirus 3 and comparison with other rhinoviruses. Acta Crystallographica Section A Foundations of Crystallography. 52(a1). C183–C183. 2 indexed citations

McKinlay, M A. (1993). Discovery and development of antipicornaviral agents.. PubMed. 88. 109–15. 10 indexed citations

McKinlay, M A. (1992). Treatment of the Picornavirus Common Cold by Inhibitors of Viral Uncoating and Attachment. Annual Review of Microbiology. 46(1). 635–654. 81 indexed citations

Jubelt, Burk, et al.. (1989). Clearance of a Persistent Human Enterovirus Infection of the Mouse Central Nervous System by the Antiviral Agent Disoxaril. The Journal of Infectious Diseases. 159(5). 866–871. 20 indexed citations

Pevear, D.C., Markus Otto, M A McKinlay, et al.. (1989). Inhibitors of viral uncoating. Pharmacology & Therapeutics. 42(3). 289–305. 23 indexed citations

10.

McKinlay, M A & Michael G. Rossmann. (1989). Rational Design of Antiviral Agents. The Annual Review of Pharmacology and Toxicology. 29(1). 111–122. 15 indexed citations

11.

Heinz, B.A., Roland R. Rueckert, D A Shepard, et al.. (1989). Genetic and molecular analyses of spontaneous mutants of human rhinovirus 14 that are resistant to an antiviral compound. Journal of Virology. 63(6). 2476–2485. 101 indexed citations

12.

DIANA, G. D., et al.. (1989). In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug. Antimicrobial Agents and Chemotherapy. 33(12). 2069–2074. 52 indexed citations

13.

Pevear, D.C., Peter J. Felock, Michael G. Rossmann, et al.. (1989). Conformational change in the floor of the human rhinovirus canyon blocks adsorption to HeLa cell receptors. Journal of Virology. 63(5). 2002–2007. 151 indexed citations

14.

Zeichhardt, Heinz, Michaël Otto, M A McKinlay, Peter Willingmann, & K.‐O. Habermehl. (1987). Inhibition of poliovirus uncoating by disoxaril (WIN 51711). Virology. 160(1). 281–285. 57 indexed citations

15.

DIANA, G. D., et al.. (1986). ChemInform Abstract: [[(4,5‐Dihydro‐2‐oxazolyl)phenoxy]alkyl]isoxazoles. Inhibitors of Picornavirus Uncoating.. Chemischer Informationsdienst. 17(14). 1 indexed citations

16.

Fox, Margaret, Michaël Otto, & M A McKinlay. (1986). Prevention of rhinovirus and poliovirus uncoating by WIN 51711, a new antiviral drug. Antimicrobial Agents and Chemotherapy. 30(1). 110–116. 134 indexed citations

17.

McKinlay, M A, et al.. (1986). Oral efficacy of WIN 51711 in mice infected with human poliovirus. Antimicrobial Agents and Chemotherapy. 29(1). 30–32. 40 indexed citations

18.

McKinlay, M A, et al.. (1986). Use of WIN 51711 to Prevent Echovirus Type 9-Induced Paralysis in Suckling Mice. The Journal of Infectious Diseases. 154(4). 676–681. 23 indexed citations

19.

McKinlay, M A, et al.. (1984). Virucidal activity of glutaric acid and evidence for dual mechanism of action. Antimicrobial Agents and Chemotherapy. 26(6). 924–927. 13 indexed citations

20.

McKinlay, M A, et al.. (1982). Prevention of human poliovirus-induced paralysis and death in mice by the novel antiviral agent arildone. Antimicrobial Agents and Chemotherapy. 22(6). 1022–1025. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact